PCR primers and conditions for expression analysis of DNMT or MBP ( DNMT1 DNMT3A, DNMT3B, MeCP, MBD1, MBD2 and MBD4) were published elsewhere ( 28).	"( DNMT1	66	73	Protein"	"DNMT3A	74	80	Protein"	"DNMT3B	82	88	Protein"	"MeCP	90	94	Protein"	"MBD1	96	100	Protein"	"MBD2	102	106	Protein"	"MBD4	111	115	Protein"	"[{""token"": ""( DNMT1"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""DNMT3A"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""DNMT3B"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Protein""}, {""token"": ""MeCP"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""MBD1"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Protein""}, {""token"": ""MBD2"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""MBD4"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Protein""}]"
To determine whether Foxp3 functioned by directly signaling through CREB, we utilized expression vectors encoding CREB - 1 or c - Jun ( a member of the activator protein 1 family of transcription factors) fused in - frame to the Gal4 - BD ( Gal4 - BD - CREB - 1 and Gal4 - BD - c - Jun).	"Foxp3	21	26	Protein"	"CREB - 1	114	122	Protein"	"c - Jun	126	133	Protein"	"activator protein 1	152	171	Protein"	"Gal4	229	233	Protein"	"Gal4 - BD - CREB - 1	241	261	Protein"	"Gal4 - BD - c - Jun	266	285	Protein"	"[{""token"": ""Foxp3"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Protein""}, {""token"": ""CREB - 1"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Protein""}, {""token"": ""c - Jun"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Protein""}, {""token"": ""activator protein 1"", ""start_span"": 152, ""end_span"": 171, ""type"": ""Protein""}, {""token"": ""Gal4"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Protein""}, {""token"": ""Gal4 - BD - CREB - 1"", ""start_span"": 241, ""end_span"": 261, ""type"": ""Protein""}, {""token"": ""Gal4 - BD - c - Jun"", ""start_span"": 266, ""end_span"": 285, ""type"": ""Protein""}]"
There was no significant difference in the expression of IL15 and IFNgamma between LMP1 transgenic lymphocytes and lymphoma cells, suggesting that upregulation of IL15 and IFNgamma is induced by LMP1 expression in healthy lymphocytes but is not a unique property of malignant lymphocytes.	"IL15	57	61	Protein"	"IFNgamma	66	74	Protein"	"LMP1	83	87	Protein"	"lymphoma cells	115	129	Protein"	"IL15	163	167	Protein"	"IFNgamma	172	180	Protein"	"LMP1	195	199	Protein"	"[{""token"": ""IL15"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""IFNgamma"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""lymphoma cells"", ""start_span"": 115, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""IL15"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Protein""}, {""token"": ""IFNgamma"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Protein""}]"
Interestingly, both wild - type and LMP1 transgenic lymphomas were similarly susceptible to triciribine, BAY11 - 7085, and cucurbitacin I treatments, but not SB202190, AG490, or U0126 treatment, suggesting that activation of Akt, NFkappaB, and Stat3 but not MAPK pathways are characteristics associated with malignant transformation ( Figure 7). rapamycin, an inhibitor of mTOR, did not affect the viability of the transgenic lymphocytes or lymphoma cells, confirming that mTOR is not targeted by Akt activation in LMP1 transgenic lymphocytes or malignant lymphoma cells ( Figure 7).	"LMP1	36	40	Protein"	"Akt	225	228	Protein"	"Stat3	244	249	Protein"	"mTOR	373	377	Protein"	"mTOR	473	477	Protein"	"Akt	497	500	Protein"	"LMP1	515	519	Protein"	"[{""token"": ""LMP1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""Akt"", ""start_span"": 225, ""end_span"": 228, ""type"": ""Protein""}, {""token"": ""Stat3"", ""start_span"": 244, ""end_span"": 249, ""type"": ""Protein""}, {""token"": ""mTOR"", ""start_span"": 373, ""end_span"": 377, ""type"": ""Protein""}, {""token"": ""mTOR"", ""start_span"": 473, ""end_span"": 477, ""type"": ""Protein""}, {""token"": ""Akt"", ""start_span"": 497, ""end_span"": 500, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 515, ""end_span"": 519, ""type"": ""Protein""}]"
Runx3 bound to the Prf1 and Gzmb transcription start sites ( TSS); to a known IL - 2 responsive enhancer located near - 1 kb of the Prf1 gene ( 23); to the distal CTL - specific DNase I hypersensitive site 9 in the Prf1 locus ( 24); to the Ifng promoter near the TSS, as previously reported for Th1 cells ( 10); and to several DNase I hypersensitive sites in the Ifng locus ( Fig. 3 D and not depicted) ( 25).	"Runx3	0	5	Protein"	"Prf1	19	23	Protein"	"Gzmb	28	32	Protein"	"Prf1	132	136	Protein"	"Prf1	215	219	Protein"	"Ifng	240	244	Protein"	"Ifng	363	367	Protein"	"[{""token"": ""Runx3"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Protein""}, {""token"": ""Prf1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Protein""}, {""token"": ""Gzmb"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Protein""}, {""token"": ""Prf1"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Protein""}, {""token"": ""Prf1"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Protein""}, {""token"": ""Ifng"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Protein""}, {""token"": ""Ifng"", ""start_span"": 363, ""end_span"": 367, ""type"": ""Protein""}]"
Reconstitution of Runx3 - / - CD8 + T cells with Runx3 restored expression of Eomes as well as perforin, granzyme B, and IFN - gamma ( Fig. 4, A and B).	"Runx3	18	23	Protein"	"CD8	30	33	Protein"	"Runx3	49	54	Protein"	"Eomes	78	83	Protein"	"perforin	95	103	Protein"	"granzyme B	105	115	Protein"	"IFN - gamma	121	132	Protein"	"[{""token"": ""Runx3"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Protein""}, {""token"": ""CD8"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Protein""}, {""token"": ""Runx3"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""Eomes"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Protein""}, {""token"": ""perforin"", ""start_span"": 95, ""end_span"": 103, ""type"": ""Protein""}, {""token"": ""granzyme B"", ""start_span"": 105, ""end_span"": 115, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Protein""}]"
The following antibodies used for intracellular or surface stains were obtained from eBioscience: anti - IL - 2, anti - IFN - gamma, anti - TNF, anti - granzyme B, anti - CD8, anti - CD25, and anti - CD44.	"IL - 2	105	111	Protein"	"IFN - gamma	120	131	Protein"	"TNF	140	143	Protein"	"granzyme B	152	162	Protein"	"CD8	171	174	Protein"	"CD25	183	187	Protein"	"CD44	200	204	Protein"	"[{""token"": ""IL - 2"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""TNF"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Protein""}, {""token"": ""granzyme B"", ""start_span"": 152, ""end_span"": 162, ""type"": ""Protein""}, {""token"": ""CD8"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Protein""}, {""token"": ""CD44"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Protein""}]"
We therefore further fractionated the positively selected CD8 + T cells from Runx3 KO mice into CD8 + CD4 - SP or CD8 + CD4 + DP cells by separation using anti - CD4 magnetic beads.	"CD8	58	61	Protein"	"Runx3	77	82	Protein"	"CD8	96	99	Protein"	"CD4	102	105	Protein"	"CD8	114	117	Protein"	"CD4	120	123	Protein"	"CD4	162	165	Protein"	"[{""token"": ""CD8"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""Runx3"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""CD8"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Protein""}, {""token"": ""CD8"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Protein""}]"
( B) Northern blot analysis of Prf1 and GzmB mRNA expression in WT or T - bet - deficient CD8 + T cells activated and either left uninfected ( uninf) or transduced with retroviruses expressing Eomes - VP16 ( Eo - VP16) or an empty IRES - GFP cassette ( GFP).	"Prf1	31	35	Protein"	"GzmB	40	44	Protein"	"T - bet	70	77	Protein"	"CD8	90	93	Protein"	"Eomes - VP16	193	205	Protein"	"Eo - VP16	208	217	Protein"	"GFP	238	241	Protein"	"[{""token"": ""Prf1"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Protein""}, {""token"": ""GzmB"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""T - bet"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Protein""}, {""token"": ""CD8"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""Eomes - VP16"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Protein""}, {""token"": ""Eo - VP16"", ""start_span"": 208, ""end_span"": 217, ""type"": ""Protein""}, {""token"": ""GFP"", ""start_span"": 238, ""end_span"": 241, ""type"": ""Protein""}]"
( A) Western analysis of Runx3, Eomes, T - bet, and perforin expression in Runx3 + / + versus Runx3 - / - CD8 + SP T cells differentiated for 6 d.	"Runx3	25	30	Protein"	"Eomes	32	37	Protein"	"T - bet	39	46	Protein"	"perforin	52	60	Protein"	"Runx3	75	80	Protein"	"Runx3	94	99	Protein"	"CD8	106	109	Protein"	"[{""token"": ""Runx3"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Protein""}, {""token"": ""Eomes"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""T - bet"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Protein""}, {""token"": ""perforin"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Protein""}, {""token"": ""Runx3"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""Runx3"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""CD8"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Protein""}]"
( C) Expression of granzyme B, IFN - gamma, TNF, and IL - 2 by resting or restimulated ( 6 h) Runx3 + / + versus Runx3 - / - CD8 + SP T cells differentiated for 6 d.	"granzyme B	19	29	Protein"	"IFN - gamma	31	42	Protein"	"TNF	44	47	Protein"	"IL - 2	53	59	Protein"	"Runx3	94	99	Protein"	"Runx3	113	118	Protein"	"CD8	125	128	Protein"	"[{""token"": ""granzyme B"", ""start_span"": 19, ""end_span"": 29, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 31, ""end_span"": 42, ""type"": ""Protein""}, {""token"": ""TNF"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Protein""}, {""token"": ""Runx3"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""Runx3"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Protein""}, {""token"": ""CD8"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Protein""}]"
Runx3 is present in naive CD8 + T cells and represses Runx1 and induces Eomes, perforin, granzyme B, and IFN - gamma expression.	"Runx3	0	5	Protein"	"CD8	26	29	Protein"	"Runx1	54	59	Protein"	"Eomes	72	77	Protein"	"perforin	79	87	Protein"	"granzyme B	89	99	Protein"	"IFN - gamma	105	116	Protein"	"[{""token"": ""Runx3"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Protein""}, {""token"": ""CD8"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Protein""}, {""token"": ""Runx1"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Protein""}, {""token"": ""Eomes"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Protein""}, {""token"": ""perforin"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""granzyme B"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Protein""}]"
In vitro human CD4 + and CD8 + T cell clones, or mouse CD4 + T cells that produce both interferon - gamma ( IFN - gamma) and IL - 10, can be differentiated by T cell receptor ( TCR) - stimulation in the presence of IL - 12 ( Chang et al., 2007; Gerosa et al., 1996; Jeannin et al., 1996; Meyaard et al., 1996; Windhagen et al., 1996).	"CD4	15	18	Protein"	"CD8	25	28	Protein"	"CD4	55	58	Protein"	"interferon - gamma	87	105	Protein"	"IFN - gamma	108	119	Protein"	"IL - 10	125	132	Protein"	"IL - 12	215	222	Protein"	"[{""token"": ""CD4"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Protein""}, {""token"": ""CD8"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 87, ""end_span"": 105, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Protein""}, {""token"": ""IL - 12"", ""start_span"": 215, ""end_span"": 222, ""type"": ""Protein""}]"
Culture of naive CD4 + T cells in an APC - free system by stimulation with anti - CD3 and anti - CD28 antibodies in the presence of IL - 12 resulted in IFN - gamma - producing Th1 cells, a proportion of which coproduced IL - 10, as did Th2 cells resulting from culture in IL - 4 ( Figure S1B).	"CD4	17	20	Protein"	"CD3	82	85	Protein"	"CD28	97	101	Protein"	"IL - 12	132	139	Protein"	"IFN - gamma	152	163	Protein"	"IL - 10	220	227	Protein"	"IL - 4	272	278	Protein"	"[{""token"": ""CD4"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""IL - 12"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 152, ""end_span"": 163, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 220, ""end_span"": 227, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 272, ""end_span"": 278, ""type"": ""Protein""}]"
To investigate whether the inability of STAT4 - deficient T cells to produce IL - 10 might be due to the absence of IFN - gamma, as suggested before ( Shaw et al., 2006), we differentiated DO11. 10 or DO11. 10 IFN - gamma - deficient naive CD4 + T cells in the presence of IL - 12 and increasing doses of OVA.	"STAT4	40	45	Protein"	"IL - 10	77	84	Protein"	"IFN - gamma	116	127	Protein"	"IFN - gamma	210	221	Protein"	"CD4	240	243	Protein"	"IL - 12	273	280	Protein"	"OVA	305	308	Protein"	"[{""token"": ""STAT4"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 210, ""end_span"": 221, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Protein""}, {""token"": ""IL - 12"", ""start_span"": 273, ""end_span"": 280, ""type"": ""Protein""}, {""token"": ""OVA"", ""start_span"": 305, ""end_span"": 308, ""type"": ""Protein""}]"
Th1 cells induced in the first week to produce IL - 10 by culture with high antigen doses and IL - 12 lost their ability to express IL - 10 when recultured with low doses of OVA, which could be compensated for, to some extent, by addition of IL - 12 to the secondary cultures ( Figure 4F), again suggesting that antigen dose and IL - 12 signals cooperate for the induction of IL - 10.	"IL - 10	47	54	Protein"	"IL - 12	94	101	Protein"	"IL - 10	132	139	Protein"	"OVA	174	177	Protein"	"IL - 12	242	249	Protein"	"IL - 12	329	336	Protein"	"IL - 10	376	383	Protein"	"[{""token"": ""IL - 10"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""IL - 12"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Protein""}, {""token"": ""OVA"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Protein""}, {""token"": ""IL - 12"", ""start_span"": 242, ""end_span"": 249, ""type"": ""Protein""}, {""token"": ""IL - 12"", ""start_span"": 329, ""end_span"": 336, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 376, ""end_span"": 383, ""type"": ""Protein""}]"
It has also been shown that maintenance of IL - 10 expression is conditional on IL - 12 or IL - 4 unless the IL - 10 gene is imprinted by GATA - 3 ( Chang et al., 2007), which can remodel the IL - 10 locus, thus explaining the highest amounts of IL - 10 produced by Th2 cells ( Chang et al., 2007; Shoemaker et al., 2006).	"IL - 10	43	50	Protein"	"IL - 12	80	87	Protein"	"IL - 4	91	97	Protein"	"IL - 10	109	116	Protein"	"GATA - 3	138	146	Protein"	"IL - 10	192	199	Protein"	"IL - 10	246	253	Protein"	"[{""token"": ""IL - 10"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Protein""}, {""token"": ""IL - 12"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Protein""}, {""token"": ""GATA - 3"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 246, ""end_span"": 253, ""type"": ""Protein""}]"
The amounts of TRAF2, TRAF3, and cIAP1 in CD40 immunoprecipitates from HOIP - deficient cells were similar to those from parental A20. 2J cells, indicating that HOIP is not required for the association of these proteins with CD40.	"TRAF2	15	20	Protein"	"TRAF3	22	27	Protein"	"cIAP1	33	38	Protein"	"CD40	42	46	Protein"	"HOIP	71	75	Protein"	"HOIP	161	165	Protein"	"CD40	225	229	Protein"	"[{""token"": ""TRAF2"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Protein""}, {""token"": ""TRAF3"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Protein""}, {""token"": ""cIAP1"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Protein""}, {""token"": ""HOIP"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Protein""}, {""token"": ""HOIP"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 225, ""end_span"": 229, ""type"": ""Protein""}]"
A20. 2J and HOIP - deficient cells transduced with an empty retroviral vector ( A20. 2J + pMIP and HOIP - / - + pMIP, respectively), or HOIP - deficient cells transduced with a HOIP - encoding retrovirus ( HOIP - / - + HOIP) were cultured overnight with agonistic anti - CD40 or an isotype control antibody ( iso), with or without IL - 4.	"HOIP	12	16	Protein"	"HOIP	99	103	Protein"	"HOIP	136	140	Protein"	"HOIP	177	181	Protein"	"HOIP	206	210	Protein"	"HOIP	219	223	Protein"	"IL - 4	331	337	Protein"	"[{""token"": ""HOIP"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Protein""}, {""token"": ""HOIP"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Protein""}, {""token"": ""HOIP"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Protein""}, {""token"": ""HOIP"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Protein""}, {""token"": ""HOIP"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Protein""}, {""token"": ""HOIP"", ""start_span"": 219, ""end_span"": 223, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 331, ""end_span"": 337, ""type"": ""Protein""}]"
To determine if the Sharpin mutation affects DC development in lymphoid tissues, mouse spleens were examined for the distribution of conventional DC ( cDC; CD11c + CD8alpha + and CD11c + CD8alpha -) [ 13] and plasmacytoid DC ( pDC; CD11c - PDCA - 1 +) [ 14].	"Sharpin	20	27	Protein"	"CD11c	156	161	Protein"	"CD8alpha	164	172	Protein"	"CD11c	179	184	Protein"	"CD8alpha	187	195	Protein"	"CD11c	232	237	Protein"	"PDCA - 1	240	248	Protein"	"[{""token"": ""Sharpin"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Protein""}, {""token"": ""CD11c"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Protein""}, {""token"": ""CD8alpha"", ""start_span"": 164, ""end_span"": 172, ""type"": ""Protein""}, {""token"": ""CD11c"", ""start_span"": 179, ""end_span"": 184, ""type"": ""Protein""}, {""token"": ""CD8alpha"", ""start_span"": 187, ""end_span"": 195, ""type"": ""Protein""}, {""token"": ""CD11c"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Protein""}, {""token"": ""PDCA - 1"", ""start_span"": 240, ""end_span"": 248, ""type"": ""Protein""}]"
